Najeeb Tallat
Department of Otolaryngology and Head and Neck Surgery, Pakistan Institute of Medical Sciences, Islamabad (PIMS).
J Coll Physicians Surg Pak. 2006 Mar;16(3):179-82.
To analyze clinicopathological presentation of tongue cancers and to calculate survival rates (SR) with disease free survival rates (DFSR) and recurrence rates (RR) in different treatment modalities and to compare the results of surgery alone and radiotherapy alone in stage I and stage II disease and to calculate better option of treatment in early tongue cancers.
A longitudinal study.
Department of Otolaryngology and Head and Neck Surgery, Pakistan Institute of Medical Sciences, Islamabad (PIMS) from January 1987 to June 1998.
Case histories of 67 patients were collected from departmental record. Clinical data included age at diagnosis, gender of patient, location of tumour, presenting symptoms and their duration, biopsy report, predominant histological pattern of tumour, nodal status, stage of tumour, treatment modality employed, tumour recurrence, metastasis and survival rates with disease-free survival rates after 2 year s follow-up.
Among 67 patients there were 31 males and 36 females. Mean age was 50 years (range 20 to 80 years). Sixtyseven patients with primary cancer of tongue constituted 38.8% of oral cavity cancers during period of 1987 to 1998 in PIMS. Smoking, poor orodental hygiene (PODH) and betel nuts chewing were the main risk factors. Odynophagia and painful ulcers on lateral border of tongue were the main clinical symptoms with average duration of 7 months. Regional lymph nodes were palpable in 32.8%, 5.5% was in stage I, 35.8% in stage II, 29.8% in stage III, and 28.3% was in stage IV. No patient was found to have distant metastasis. Histopathology in 94% of cases was squamous cell carcinoma (SCC). Recurrence and survival rates were determined in 49 patients. Average time of recurrence was 12.5 months. Recurrence was 100% loco regional (LR). It was 85.7% in patients treated with radiotherapy (RT) alone, 42.1% in patients treated with surgery alone and 31.2% in patients treated with combination of surgery and radiotherapy (RT). Two years survival was 64.2%, 84.2%, 93.7% and 2 years disease-free survival was 14.2%, 57.8% and 68.7% in patients treated with radiotherapy, surgery and combination of radiotherapy (RT) and surgery respectively.
In early stages of SCC of tongue either surgery or RT could be used but surgery is better option to decrease the recurrence and to improve the quality of life. In late stages combination of surgery and RT is better than single modality treatment.
分析舌癌的临床病理表现,计算不同治疗方式下的生存率(SR)、无病生存率(DFSR)和复发率(RR),比较Ⅰ期和Ⅱ期疾病单纯手术与单纯放疗的结果,计算早期舌癌的更佳治疗选择。
一项纵向研究。
1987年1月至1998年6月,位于伊斯兰堡的巴基斯坦医学科学研究所耳鼻喉头颈外科。
从科室记录中收集67例患者的病历。临床数据包括诊断时的年龄、患者性别、肿瘤位置、出现的症状及其持续时间、活检报告、肿瘤的主要组织学类型、淋巴结状态、肿瘤分期、采用的治疗方式、肿瘤复发、转移以及随访2年后的生存率和无病生存率。
67例患者中,男性31例,女性36例。平均年龄为50岁(范围20至80岁)。1987年至1998年期间,67例原发性舌癌患者占巴基斯坦医学科学研究所口腔癌患者的38.8%。吸烟、口腔卫生差(PODH)和嚼槟榔是主要危险因素。吞咽痛和舌侧缘疼痛性溃疡是主要临床症状,平均持续时间为7个月。32.8%可触及区域淋巴结,5.5%为Ⅰ期,35.8%为Ⅱ期,29.8%为Ⅲ期,28.3%为Ⅳ期。未发现远处转移患者。94%的病例组织病理学检查为鳞状细胞癌(SCC)。对49例患者测定了复发率和生存率。平均复发时间为12.5个月。复发均为局部区域(LR)复发。单纯放疗(RT)患者的复发率为85.7%,单纯手术患者为42.1%,手术联合放疗患者为31.2%。放疗、手术以及放疗(RT)与手术联合治疗的患者2年生存率分别为64.2%、84.2%、93.7%,2年无病生存率分别为14.2%、57.8%和68.7%。
在舌鳞状细胞癌早期,手术或放疗均可采用,但手术是降低复发率和提高生活质量的更佳选择。在晚期,手术与放疗联合治疗优于单一治疗方式。